Table 1. Clinical data for the patients included in the study.
| Leprosy classification | Leprosy reactions | ||||||
|---|---|---|---|---|---|---|---|
| WHO* | n (%) | RJ** | n (%) | Neuritis | Type 1 | Type 2 | No previous reactions |
| PB | 11 (11.5%) | TT | 11 (11.5%) | 2 | 1 | 0 | 8 |
| MB | 85 (88.5%) | BT | 31 (32.3%) | 3 | 2 | 0 | 26 |
| BB | 33 (34.4%) | 2 | 4 | 0 | 28 | ||
| BL | 13 (13.5%) | 3 | 9 | 3 | 2 | ||
| LL | 8 (8.3%) | 2 | 0 | 3 | 5 | ||
| Total | 96 | 96 | 12 | 16 | 6 | 69 | |
n: number of patients, with percentages in parentheses.
*WHO: Operational classification proposed by the World Health Organization.
** RJ: Ridley-Jopling classification.